My team develops imaging instrumentation to diagnose or assist in diagnosis of tumor tissue. We have developed an optical imaging method and a software that can non-invasively diagnose cutaneous melanoma with more than 95% specificity and sensitivity. We are also developing an imaging-based method using photoacoustic imaging to diagnose breast cancer in dense breast. Another development is to help neurosurgeons to identify the tumor residuals after brain surgery.
Kamran Avanaki, PhD, MS
Title & Department
College of Medicine
Cancer Prevention And Control (CPC)